From: Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?
Distant metastasis-free survival | Disease-free survival | Overall survival | ||||
---|---|---|---|---|---|---|
P | Relative risk (95% confidence interval) | P | Relative risk (95% confidence interval) | P | Relative risk (95% confidence interval) | |
Age | ||||||
> 50 years versus < 50 years | 0.14 | 0.50 (0.20–1.26) | 0.20 | 0.56 (0.23–1.36) | 0.13 | 0.43 (0.15–1.29) |
T stage | ||||||
T3/T4 versus T1/T2 | 0.01 | 3.16 (1.32–7.58) | 0.03 | 2.57 (1.08–6.11) | 0.03 | 3.03 (1.08–8.51) |
Estrogen receptor | ||||||
Positive versus negative | 0.32 | 0.64 (0.26–1.56) | 0.18 | 0.54 (0.22–1.33) | - | |
Number of positive lymph nodes | ||||||
4+ versus 1–3 | 0.02 | 4.06 (1.17–14.01) | 0.02 | 4.42 (1.28–15.32) | 0.16 | 3.00 (0.64–13.97) |
hif-1α expression | ||||||
Yes versus no | 0.18 | 1.94 (0.73–5.17) | 0.30 | 1.68 (0.62–4.47) | 0.09 | 2.66 (0.83–8.51) |